SCPH
Companies
NASDAQ
ScPharmaceuticals Inc.
Health Care
$3.92
+$0.38 (+10.73%)
Price Chart
Overview
About SCPH
scpharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (iv) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs.
Market Cap
$135.2M
Volume
2.2M
Avg. Volume
2.4M
P/E Ratio
-2.9452055
Dividend Yield
0.00%
Employees
92.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.88
Moderate Correlation
Volatility
High (0.58)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, SCPH shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$135.2M
Volume2.2M
P/E Ratio-2.95
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 20, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025